Related references
Note: Only part of the references are listed.Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis
Jay Ramchand et al.
JACC-CARDIOVASCULAR IMAGING (2020)
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Physiological cyclic stretch up-regulates angiotensin-converting enzyme 2 expression to reduce proliferation and migration of vascular smooth muscle cells
Jiantao Song et al.
BIOSCIENCE REPORTS (2020)
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Tomasz J. Guzik et al.
CARDIOVASCULAR RESEARCH (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
The Science Underlying COVID-19 Implications for the Cardiovascular System
Peter P. Liu et al.
CIRCULATION (2020)
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
Peng Zhang et al.
CIRCULATION RESEARCH (2020)
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2
Mahmoud Gheblawi et al.
CIRCULATION RESEARCH (2020)
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
Daniel Batlle et al.
CLINICAL SCIENCE (2020)
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors
Iziah E. Sama et al.
EUROPEAN HEART JOURNAL (2020)
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Luka Nicin et al.
EUROPEAN HEART JOURNAL (2020)
Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?
Tiantian Yan et al.
FASEB JOURNAL (2020)
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19
Hisashi Kai et al.
HYPERTENSION RESEARCH (2020)
Blood flow restriction exercise stimulates mobilization of hematopoietic stem/progenitor cells and increases the circulating ACE2 levels in healthy adults
Shrinidh Joshi et al.
JOURNAL OF APPLIED PHYSIOLOGY (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
Celestino Sardu et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang et al.
ACTA PHARMACOLOGICA SINICA (2020)
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle et al.
LIFE SCIENCE ALLIANCE (2020)
SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications
Sonja Gross et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
The protein expression profile of ACE2 in human tissues
Feria Hikmet et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Angiotensin-converting enzyme 2 augments the effects of endothelial progenitor cells-exosomes on vascular smooth muscle cell phenotype transition
Jinju Wang et al.
CELL AND TISSUE RESEARCH (2020)
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga et al.
NATURE REVIEWS CARDIOLOGY (2020)
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
Emma S. Winkler et al.
NATURE IMMUNOLOGY (2020)
Sequence Analysis and Structure Prediction of SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close Relatedness to Bat Coronavirus
Chittaranjan Baruah et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Ophiopogonin D Increases SERCA2a Interaction with Phospholamban by Promoting CYP2J3 Upregulation
Jia Wang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
Ke Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
Upinder Kaur et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
Filippo Scialo et al.
LUNG (2020)
Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2
Morag J. Young et al.
JOURNAL OF ENDOCRINOLOGY (2020)
Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure
Julio A. Chirinos et al.
HYPERTENSION (2020)
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Luka Nicin et al.
EUROPEAN HEART JOURNAL (2020)
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors
Iziah E. Sama et al.
EUROPEAN HEART JOURNAL (2020)
Assessing the effects of Ang-(1-7) therapy following transient middle cerebral artery occlusion
M. M. C. Arroja et al.
SCIENTIFIC REPORTS (2019)
Unique mechanistic insights into the beneficial effects of angiotensin-(1-7) on the prevention of cardiac fibrosis: A metabolomic analysis of primary cardiac fibroblasts
Yun-lin Chen et al.
EXPERIMENTAL CELL RESEARCH (2019)
Hypoxic regulation of angiotensin-converting enzyme 2 and Mas receptor in human CD34+ cells
Shrinidh Joshi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-κB and Nrf2 pathways
Y. Fang et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2019)
Activating Mas receptor protects human pulmonary microvascular endothelial cells against LPS-induced apoptosis via the NF-kB p65/P53 feedback pathways
Weifeng Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The angiotensin-(1-7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation
Alejandra Romero et al.
AGING CELL (2019)
The renin-angiotensin system: going beyond the classical paradigms
Robson Augusto Souza Santos et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)
Angiotensin-(1-7) and Vascular Function: The Clinical Context
Rhian M. Touyz et al.
HYPERTENSION (2018)
CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes
Yuanyuan Tie et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension
Jiao Zhang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension
Anna R. Hemnes et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY
Steven J. Forrester et al.
PHYSIOLOGICAL REVIEWS (2018)
THE ACE2/ANGIOTENSIN-(1-7)/MAS AXIS OF THE RENIN-ANGIOTENSIN SYSTEM: FOCUS ON ANGIOTENSIN-(1-7)
Robson Augusto Souza Santos et al.
PHYSIOLOGICAL REVIEWS (2018)
Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease
Jay Ramchand et al.
PLOS ONE (2018)
rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
Anandharajan Rathinasabapathy et al.
FRONTIERS IN PHYSIOLOGY (2018)
Angiotensin II Type 2 Receptor and Receptor Mas Are Colocalized and Functionally Interdependent in Obese Zucker Rat Kidney
Sanket N. Patel et al.
HYPERTENSION (2017)
Evidence for Heterodimerization and Functional Interaction of the Angiotensin Type 2 Receptor and the Receptor MAS
Julia Leonhardt et al.
HYPERTENSION (2017)
Vasodilator Effect of Angiotensin-(1-7) on Vascular Coronary Bed of Rats: Role of Mas, ACE and ACE2
Patricia Lanza de Moraes et al.
PROTEIN AND PEPTIDE LETTERS (2017)
Angiotensin-(1-7) Inhibits Thrombin-Induced Endothelial Phenotypic Changes and Reactive Oxygen Species Production via NADPH Oxidase 5 Downregulation
Wan-Yu Pai et al.
FRONTIERS IN PHYSIOLOGY (2017)
Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis
D. S. Skiba et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
Akram Khan et al.
CRITICAL CARE (2017)
Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes
Santosh Kumar Goru et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells
Feng Zhang et al.
ATHEROSCLEROSIS (2017)
Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism
Lirong Guo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress
Li Lin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress
Yuedong Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
G-Protein-Coupled Receptor MrgD Is a Receptor for Angiotensin-(1-7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase A
Anja Tetzner et al.
HYPERTENSION (2016)
The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice
Xingxu Wang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress
Luiza A. Rabelo et al.
PLOS ONE (2016)
The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
Laura A. Villalobos et al.
FRONTIERS IN PHARMACOLOGY (2016)
Angiotensin-(1-7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways
Feng Zhang et al.
SCIENTIFIC REPORTS (2016)
Activation of angiotensin II type 2 receptor suppresses TNF-α-induced ICAM-1 via NF-κB: possible role of ACE2
Liping Zhu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells
Neha Singh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes
Yang Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Comparison of angiotensin-(1-7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice
Jianmin Yang et al.
ATHEROSCLEROSIS (2015)
Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice
A. M. Papinska et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
E. Bruce et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison
Daniel Villela et al.
CLINICAL SCIENCE (2015)
Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways
Xiang Xiao et al.
EXPERIMENTAL CELL RESEARCH (2015)
ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response
Yue-Hui Zhang et al.
INFLAMMATION RESEARCH (2015)
Angiotensin-(1-7) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor
Yanping Liu et al.
MOLECULAR MEDICINE (2015)
Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFκB inflammatory pathway
Ji C. Bihl et al.
VASCULAR PHARMACOLOGY (2015)
Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
Masato Furuhashi et al.
AMERICAN JOURNAL OF HYPERTENSION (2015)
ACE2 and AT4R are present in diseased human blood vessels
A Zulli et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2015)
Angiotensin 1-7 Protects against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas Receptor
Dharmani Murugan et al.
PLOS ONE (2015)
Angiotensin-Converting Enzyme 2 Decreases Formation and Severity of Angiotensin II-Induced Abdominal Aortic Aneurysms
Sean E. Thatcher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Angiotensin-(1-7) attenuates angiotensin II-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts
Xiaoling Tao et al.
BIOLOGY OF THE CELL (2014)
Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation
Makoto Sahara et al.
CARDIOVASCULAR RESEARCH (2014)
Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421
Daniel W. Lambert et al.
CLINICAL SCIENCE (2014)
Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress
Nicola E. Clarke et al.
CLINICAL SCIENCE (2014)
Angiotensin II and Vascular Injury
Augusto C. Montezano et al.
CURRENT HYPERTENSION REPORTS (2014)
Angiotensin-Converting Enzyme 2 Is a Critical Determinant of Angiotensin II-Induced Loss of Vascular Smooth Muscle Cells and Adverse Vascular Remodeling
Vaibhav B. Patel et al.
HYPERTENSION (2014)
Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension
Vinayak Shenoy et al.
HYPERTENSION (2014)
TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
Adeline Heurich et al.
JOURNAL OF VIROLOGY (2014)
ACE2/Ang-(1-7) signaling and vascular remodeling
Zhang ZhenZhou et al.
SCIENCE CHINA-LIFE SCIENCES (2014)
From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
Sheila K. Patel et al.
FRONTIERS IN PHYSIOLOGY (2014)
Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury
Gerry T. M. Wagenaar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models
Vinayak Shenoy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature
Aurelie Nguyen Dinh Cat et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats
Zhen Yang et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2013)
ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
A. C. Simoes e Silva et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
Manuel Haschke et al.
CLINICAL PHARMACOKINETICS (2013)
Activation of the ACE2/Angiotensin-(1-7)/Mas Receptor Axis Enhances the Reparative Function of Dysfunctional Diabetic Endothelial Progenitors
Yagna P. R. Jarajapu et al.
DIABETES (2013)
Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats
Jennifer Lo et al.
EXPERIMENTAL PHYSIOLOGY (2013)
Angiotensin-Converting Enzyme 2 Priming Enhances the Function of Endothelial Progenitor Cells and Their Therapeutic Efficacy
Ji Chen et al.
HYPERTENSION (2013)
Angiotensin-(1-7)-Induced Renal Vasodilation in Hypertensive Humans Is Attenuated by Low Sodium Intake and Angiotensin II Co-Infusion
Daan J. L. van Twist et al.
HYPERTENSION (2013)
Angiotensin II-Independent Angiotensin-(1-7) Formation in Rat Hippocampus Involvement of Thimet Oligopeptidase
Marilia G. A. G. Pereira et al.
HYPERTENSION (2013)
Angiotensin-Converting Enzyme 2 Activation Improves Endothelial Function
Rodrigo A. Fraga-Silva et al.
HYPERTENSION (2013)
Angiotensin (1-7) ameliorates angiotensin II-induced inflammation by inhibiting LOX-1 expression
Lijun Wang et al.
INFLAMMATION RESEARCH (2013)
ACE2-From the renin-angiotensin system to gut microbiota and malnutrition
Thomas Perlot et al.
MICROBES AND INFECTION (2013)
Angiotensin-(1-7) inhibits vascular calcification in rats
Yu-Bin Sui et al.
PEPTIDES (2013)
Angiotensin-(1-7) inhibits autophagy in the brain of spontaneously hypertensive rats
Teng Jiang et al.
PHARMACOLOGICAL RESEARCH (2013)
Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways
Bei Song et al.
REGULATORY PEPTIDES (2013)
Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway
Saghir Akhtar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions
Luke J. Burchill et al.
CLINICAL SCIENCE (2012)
Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway
Ning Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Aldosterone-induced kidney injury is mediated by NFκB activation
Seiichi Fukuda et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke
Adam P. Mecca et al.
EXPERIMENTAL PHYSIOLOGY (2011)
Angiotensin II and the vascular phenotype in hypertension
Carmine Savoia et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Angiotensin AT2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension
Luis C. Matavelli et al.
HYPERTENSION (2011)
A new look at the renin-angiotensin system-Focusing on the vascular system
Aurelie Nguyen Dinh Cat et al.
PEPTIDES (2011)
Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries
Matthew J. Durand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats
Maria A. Costa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Vasoprotective and Atheroprotective Effects of Angiotensin (1-7) in Apolipoprotein E-Deficient Mice
Sonja Tesanovic et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse
Merlin C. Thomas et al.
CIRCULATION RESEARCH (2010)
Circulating Rather Than Cardiac Angiotensin-(1-7) Stimulates Cardioprotection After Myocardial Infarction
Yong Wang et al.
CIRCULATION-HEART FAILURE (2010)
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2 Prevention of Angiotensin II-Dependent Hypertension
Jan Wysocki et al.
HYPERTENSION (2010)
Angiotensin-(1-7)-Angiotensin-Converting Enzyme 2 Attenuates Reactive Oxygen Species Formation to Angiotensin II Within the Cell Nucleus
TanYa M. Gwathmey et al.
HYPERTENSION (2010)
The angiotensin II type 2 receptor in cardiovascular disease
Catherine A. Lemarie et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2010)
Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells
Cheng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension
Anderson J. Ferreira et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The Identification of a Calmodulin-Binding Domain within the Cytoplasmic Tail of Angiotensin-Converting Enzyme-2
Zon W. Lai et al.
ENDOCRINOLOGY (2009)
SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
G. Y. Oudit et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer
Yoriko Yamazato et al.
HYPERTENSION (2009)
Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes
Slava Epelman et al.
JOURNAL OF CARDIAC FAILURE (2009)
Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway
Vijay Koka et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes
Megumi Yamamuro et al.
CIRCULATION JOURNAL (2008)
Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor
Rebecca A. Lew et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function
Brit Rentzsch et al.
HYPERTENSION (2008)
Endothelial dysfunction and elevated blood pressure in Mas gene-deleted mice
Ping Xu et al.
HYPERTENSION (2008)
Update on tissue renin-angiotensin systems
Michael Bader et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions
J. C. Sluimer et al.
JOURNAL OF PATHOLOGY (2008)
Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain
Daniel W. Lambert et al.
FEBS LETTERS (2008)
Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats
Ibrahim F. Benter et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells
Walkyria O. Sampaio et al.
HYPERTENSION (2007)
Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats
D. M. R. Silva et al.
PEPTIDES (2007)
Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways
Walkyria Oliveira Sampaio et al.
HYPERTENSION (2007)
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR
Carlos Diez-Freire et al.
PHYSIOLOGICAL GENOMICS (2006)
Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat
Maria Paz Ocaranza et al.
HYPERTENSION (2006)
Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor Mas knockout mice
RAS Santos et al.
HYPERTENSION (2006)
A place in our hearts for the lowly angiotensin 1-7 peptide?
TL Reudelhuber
HYPERTENSION (2006)
Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies
G Valdés et al.
PLACENTA (2006)
Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients
S Keidar et al.
CIRCULATION RESEARCH (2005)
Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart
CH de Castro et al.
HYPERTENSION (2005)
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats
M Igase et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)
DW Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
CM Ferrario et al.
CIRCULATION (2005)
Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats
PE Walters et al.
HYPERTENSION (2005)
Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus
ZN Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Myocardial infarction increases ACE2 expression in rat and humans
LM Burrell et al.
EUROPEAN HEART JOURNAL (2005)
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors
Y Ishiyama et al.
HYPERTENSION (2004)
Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation
DJ Campbell et al.
JOURNAL OF HYPERTENSION (2004)
Low sodium diet inhibits the local counter-regulator effect of angiotensin-(1-7) on angiotensin II
AJM Roks et al.
JOURNAL OF HYPERTENSION (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism
GI Rice et al.
BIOCHEMICAL JOURNAL (2004)
Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice
DD Ellefson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
RAS Santos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Angiotensin AT1/AT2 receptors: Regulation, signalling and function
E Kaschina et al.
BLOOD PRESSURE (2003)
Angiotensin-converting enzyme 2 is an essential regulator of heart function
MA Crackower et al.
NATURE (2002)
Accelerated recovery from irradiation injury by angiotensin peptides
KE Rodgers et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors
AJ Turner et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)
Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man
S Ueda et al.
JOURNAL OF HYPERTENSION (2001)
Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension
S Sasaki et al.
HYPERTENSION (2001)
Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm
T Wilsdorf et al.
HYPERTENSION (2001)
Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo
L Fernandes et al.
HYPERTENSION (2001)
A human homolog of angiotensin-converting enzyme - Cloning and functional expression as a captopril-insensitive carboxypeptidase
SR Tipnis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man
S Ueda et al.
HYPERTENSION (2000)
Share Paper
